FDA Drug Recalls

Recalls / Class II

Class IID-846-2013

Product

Parsel Plus (reference US product: Excedrin Tension Headache) (Acetaminophen 500 mg and Caffeine 65 mg), packaged in 2-count pouches, Distributed by Novartis Consumer Health, Inc., USA and Novartis Consumer Health S.A., Brazil, for Novartis de Venezuela. The foreign packaging do not have NDC number This product was only distributed to Novartis Brazil by the recalling firm

Affected lot / code info
Lot # 10121996, Exp 7/13

Why it was recalled

Defective container: products are packaged in pouches which may not have been fully sealed

Recalling firm

Firm
Novartis Consumer Health
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10401 Hwy 6, N/A, Lincoln, Nebraska 68517-9626

Distribution

Quantity
472,000 pouches
Distribution pattern
Nationwide, Puerto Rico, Brazil and Panama

Timeline

Recall initiated
2013-06-06
FDA classified
2013-08-06
Posted by FDA
2013-08-14
Terminated
2014-11-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-846-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls